Free US stock valuation models and price target projections from professional analysts covering Wall Street expectations and analyst consensus. We help you understand fair value estimates and potential upside or downside scenarios for any stock you are considering. Our platform provides multiple valuation methods, comparable company analysis, and discounted cash flow models. Make smarter valuation decisions with our comprehensive tools and expert projections based on Wall Street research.
BioVie (BIVI) has recently traded at $1.33, reflecting a modest 1.53% uptick, as the stock continues to navigate a tight range between support at $1.26 and resistance near $1.40. Trading volumes in recent sessions have been relatively subdued compared to the stock’s historical average, suggesting a
Is BioVie (BIVI) Still a Buy After +1.53% Rally? 2026-05-14 - Algo Picks
BIVI - Stock Analysis
4114 Comments
1834 Likes
1
Dorlene
Influential Reader
2 hours ago
The market shows relative strength in growth-oriented sectors.
👍 176
Reply
2
Leniel
New Visitor
5 hours ago
US stock customer concentration analysis and revenue diversification assessment for business risk evaluation and investment safety assessment. We identify companies with too much dependency on single customers or concentrated revenue sources that could pose risks. We provide customer analysis, revenue diversification scoring, and concentration risk assessment for comprehensive coverage. Understand business risks with our comprehensive concentration analysis and diversification tools for safer investing.
👍 90
Reply
3
Moniquie
Expert Member
1 day ago
Your skills are basically legendary. 🏰
👍 254
Reply
4
Saivion
Engaged Reader
1 day ago
I need sunglasses for all this brilliance. 🕶️
👍 45
Reply
5
Yalaina
Legendary User
2 days ago
This feels like I unlocked confusion.
👍 272
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.